105 Evaluation of clarity of the STOPP/START criteria - SI Table SI1.5 Continued. START Action Clarity rating Condition Clarity rating Explanation Clarity rating F F1 ACE inhibitor or Angiotensin Receptor Blocker (if intolerant of ACE inhibitor) 67% in diabetes with evidence of renal disease i.e. dipstick proteinuria or microalbuminuria (>30mg/24 hours) with or without serum biochemical renal impairment. 67% N/A G G1 Alpha-1 receptor blocker 67% with symptomatic prostatism, where prostatectomy is not considered necessary. 50% N/A G2 5-alpha reductase inhibitor 67% with symptomatic prostatism, where prostatectomy is not considered necessary. 50% N/A G3 Topical vaginal oestrogen or vaginal oestrogen pessary 83% for symptomatic atrophic vaginitis 75% N/A H H1 High-potency opioids 17% in moderate-severe pain, where paracetamol, NSAIDs or low-potency opioids are not appropriate to the pain severity or have been ineffective. 50% N/A H2 Laxatives 17% in patients receiving opioids regularly. 75% N/A I I1 Seasonal trivalent influenza vaccine 83% annually 83% N/A I2 Pneumococcal vaccine 83% at least once after age 65 according to national guidelines 83% N/A 2
RkJQdWJsaXNoZXIy MTk4NDMw